Generic name: DAPAGLIFLOZIN PROPANEDIOL 5mg
Dosage form: tablet, film coated
Medically reviewed by Drugs.com. Last updated on Dec 30, 2019.
Prior to Initiation of FARXIGA
Assess renal function prior to initiation of FARXIGA therapy and periodically thereafter [see Warnings and Precautions (5.3)].
To improve glycemic control, the recommended starting dose of FARXIGA is 5 mg once daily, taken in the morning, with or without food. In patients tolerating FARXIGA 5 mg once daily who require additional glycemic control, the dose can be increased to 10 mg once daily.
To reduce the risk of hospitalization for heart failure, the recommended dose of FARXIGA is 10 mg once daily.
Patients with Renal Impairment
No dose adjustment is needed in patients with an eGFR greater than or equal to 45 mL/min/1.73 m2.
FARXIGA is contraindicated in patients with an eGFR less than 30 mL/min/1.73 m2 [see Contraindications (4)].
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
- What are the ingredient drugs contained in Qternmet XR?
- What is Farxiga used for and how does it work?
- Can Farxiga cause kidney damage?
- How long does it take for Farxiga to work?
More about Farxiga (dapagliflozin)
- Side Effects
- During Pregnancy or Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 106 Reviews
- Drug class: SGLT-2 inhibitors
- FDA Alerts (3)
- FDA Approval History